Filing Flows › Lucid Diagnostics (LUCD) › Q4 2024
Lucid Diagnostics (LUCD) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 24, 2025
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the fourth quarter 2024 (Q4 2024), +15% from a year earlier and +2% from the quarter before.
Lucid Diagnostics, Q4 2024: revenue $1.2M (+15% year over year), net loss $11.5M, operating cash flow −$9.9M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +2% | +15% |
| Operating profit | −$12.4M | — | — |
| Net earnings | −$11.5M | — | — |
| Operating cash flow | −$9.9M | — | — |
What changed
Revenue was $1.2M in Q4 2024, up 15% year over year and up 2% from the previous quarter.
Operating costs exceeded revenue by $12.4M, an operating margin of -1033.8%. Total costs grew 9% against revenue growth of 15%. The fastest-growing cost line was General & admin (+39%). The quarter ended with a net loss of $11.5M, narrower than the previous quarter's $12.4M loss.
Operating cash flow was −$9.9M. Non-cash charges added back $222K of depreciation and amortization and $1.1M of share-based compensation. Capital expenditures of $259K exceeded it, leaving free cash flow of −$10.1M.
Questions
What was Lucid Diagnostics' revenue in the fourth quarter 2024?
Lucid Diagnostics (LUCD) reported revenue of $1.2M for the fourth quarter 2024 (Q4 2024), +15% from a year earlier and +2% from the quarter before.
Source: Lucid Diagnostics 10-K on SEC EDGAR.